BMS and Sanofi-Aventis issued civil investigative demands

The FTC has issued civil investigative demands, which act like subpoenas, to Bristol-Myers Squibb and Sanofi-Aventis for documents relating to efforts to delay Apotex and other competition for Plavix (clopidogrel bisulfate).

You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.